Trial ID
I-MAB
Sponsor ID
TJ210001STM101
A Phase I Study of TJ210001 Administered in Subjects with Relapsed or Refractory Advanced Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Locations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
516-014
Sponsor ID
Mirati
A Multicenter, Open-Label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Trial ID
JBI-802-101
Sponsor ID
Jubilant Therapeutics
A First-in-Human, Open-Label, Dose Escalation and Expansion Study of Orally Administered JBI-802 in Patients with Advanced Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location